Nasdaq moves to delist Agape ATP (NASDAQ: ATPC) after low share price

Rhea-AI Filing Summary

Agape ATP Corporation has received a determination from Nasdaq staff to delist its securities after a prolonged share price decline. The decision follows an earlier notice that the company failed to meet Nasdaq’s minimum bid price requirement of $1.00 per share.

Nasdaq staff cited that, as of January 30, 2026, Agape ATP’s securities had a closing bid of $0.10 or less for ten consecutive trading days, triggering Nasdaq’s Low Priced Stocks rule. The company plans to request a hearing by February 9, 2026, which will temporarily prevent suspension and a Form 25-NSE filing while a panel reviews the case.

Positive

• None.

Negative

• Nasdaq staff determination to delist: Nasdaq has determined to delist Agape ATP’s securities after the closing bid stayed at $0.10 or less for ten consecutive trading days, signaling a serious continued listing deficiency under the Low Priced Stocks rule.

Insights

Equity listing and market structure analyst

Nasdaq’s move to delist Agape ATP is a materially negative listing event.

Agape ATP Corporation has been notified that Nasdaq staff determined to delist its securities after the closing bid stayed at $0.10 or less for ten consecutive trading days. This activates the Low Priced Stocks rule and follows an earlier minimum bid deficiency notice tied to the $1.00 requirement.

The company can request a hearing with a Nasdaq Hearings Panel by February 9, 2026, and it intends to do so. That request will keep the securities from being suspended and delay any Form 25-NSE filing until the panel issues a decision. However, there is no assurance in this text that continued listing will be maintained.

The outcome of the panel review will be important, as a delisting from the Nasdaq Capital Market could affect liquidity and visibility for shareholders. The company also discloses a $20,000 fee for the hearing, a modest cost compared with the potential impact of losing a national exchange listing.

8-K Event Classification

3 items: 3.01, 7.01, 9.01

3 items

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice or transferred its listing to a different exchange.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

FAQ

Why is Agape ATP (ATPC) facing a potential Nasdaq delisting?

Agape ATP is facing potential Nasdaq delisting because its securities had a closing bid of $0.10 or less for ten consecutive trading days. This triggered Nasdaq Listing Rule 5810(c)(3)(A)(iii), the Low Priced Stocks rule, following an earlier failure to meet the $1.00 minimum bid requirement.

What Nasdaq listing rules has Agape ATP (ATPC) failed to satisfy?

Agape ATP failed to satisfy Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, over 30 consecutive business days. Subsequently, its securities traded at $0.10 or less for ten consecutive trading days, triggering Listing Rule 5810(c)(3)(A)(iii) governing low priced stocks.

What options does Agape ATP (ATPC) have to contest the Nasdaq delisting?

Agape ATP can request a hearing before a Nasdaq Hearings Panel by February 9, 2026, and it intends to do so. Filing this request stays suspension of its securities and delays the Form 25-NSE delisting filing until the panel issues a decision on continued listing.

How much will the Nasdaq hearing cost Agape ATP (ATPC)?

The requested Nasdaq hearing will cost Agape ATP a $20,000 fee. While relatively small compared with potential listing benefits, it represents a direct cash expense the company incurs to seek review of the staff’s delisting determination by a Nasdaq Hearings Panel.

What did Agape ATP (ATPC) disclose under Regulation FD in this 8-K?

Agape ATP disclosed that on February 5, 2026, it issued a press release announcing Nasdaq’s delisting notice. The company also stated this Regulation FD information is furnished, not filed, meaning it is not automatically incorporated into Securities Act or Exchange Act filings unless specifically referenced.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 02/05/2026 - 09:00 AM Learn about SEC filing dates

false 0001713210 0001713210 2026-02-05 2026-02-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: February 5, 2026

AGAPE ATP CORPORATION

(Exact name of registrant as specified in its charter)

Nevada		001-41835		36-4838886
(State or other jurisdiction		(Commission		(IRS Employer
of incorporation)		File Number)		Identification No.)

1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,

Taman Desa, Kuala Lumpur, Malaysia 58100

(Address of principal executive offices) (Zip Code)

+(60) 192230099

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ATPC		NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously announced on January 29, 2026, the Company received a letter (the “Notification Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) on January 27, 2026, notifying the Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis for delisting the Company’s securities from Nasdaq.

On February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to delist the Company’s securities. The Staff’s determination was based on that as of January 30, 2026, the Company’s securities had a closing bid of $0.10 or less for the last ten consecutive trading days, and accordingly, is subject to the provisions under Listing Rule 5810(c)(3)(A)(iii), the “Low Priced Stocks” Rule.

The Company has the opportunity to request a hearing with the Hearings Panel (the “Panel”), by February 9, 2026. The Company intends to make the request on or prior to February 9, 2026. The hearing request will stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. The fee for the hearing is $20,000.

Item 7.01. Regulation FD Disclosure.

On February 5, 2026, the Company issued a press release announcing the delisting notice.

The information contained in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.		Description
99.1		Press Release
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AGAPE ATP CORPORATION
Date: February 5, 2026	By:	/s/ How Kok Choong
	Name:	How Kok Choong
	Title:	Chief Executive Officer, President, Director, Secretary and Treasurer (Principal Executive Officer)

3